MSF's recent data published in JAMA Network Open found that one pre-filled human insulin pen could be sold at a profit at an estimated generic target price of just $0.94 (R16,81), compared to the ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

The ramifications of this shift have already been felt in places like South Africa ... all insulin manufacturers, Sanofi ...

The reason for the sharp increase seems to be simple: corporate greed. Recently, though, the high price of insulin has gone too far. Government agencies at both the state and federal levels are ...

has guaranteed that Wyoming residents not enrolled in government healthcare programs can buy insulin products for $35 each month for the next five years. The settlement announced by Attorney ...

The rising price of insulin has become one of the most talked about issues across the pharma industry. Ben Hargreaves explains how Eli Lilly decided to cap its insulin price, why it has decided to ...

Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. It has now been 100 years since the first patient with diabetes received an injection of ...

In recent years, these companies have been questioned over the price of insulin in congressional hearings and investigations. In response to public pressure and changing market dynamics ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...